Form 4: Lemaitre Vascular Director Roberts Acquires Shares and Options

Director David B Roberts acquired common stock and stock options in Lemaitre Vascular, Inc. on February 18, 2025.

Summary

• On February 18, 2025, David B Roberts, a director and President of Lemaitre Vascular, Inc., acquired 129 shares of common stock and 741 stock options.
• The common stock was acquired at $0, and the director now owns 14,671 shares directly.
• The stock options have an exercise price of $100.74 and are exercisable and vest over a four-year period, with 25% vesting on December 6 of 2025, 2026, 2027, and 2028.
• The options expire on February 18, 2032.
• The director now owns 741 derivative securities directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares and options by a director is generally viewed as a positive sign, but it's a routine transaction and doesn't provide significant new information.

Positives

• The acquisition of shares and options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The vesting schedule of the restricted stock units and stock options indicates a long-term incentive plan for the director, aligning their interests with the company's performance over the next several years.

Industry Context

Form 4 filings are routine disclosures for corporate insiders and provide transparency into their transactions in the company's securities. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation in the medical device industry, used to incentivize performance and align management interests with shareholders.
• Vesting schedules, such as the four-year vesting described in the document, are standard practice to ensure long-term commitment.
• Comparable companies in the medical device space, such as Medtronic or Boston Scientific, also utilize stock options and restricted stock units as part of their executive compensation packages.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a company director.

Key Dates

Keywords

Lemaitre Vascular, Director, Stock Options, Common Stock, Acquisition, Form 4, Roberts, LMAT